Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 761

Sort by

Sort Order Select

Journal Articles

BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant

Dimana Dimitrova, Elisabetta Xue, Mustafa A. Hyder, Hyoyoung Choo-Wosoba, Kamil Rechache, Francis A. Flomerfelt, Sanchita Das, Christi McKeown, Alison Cusmano, Ruby Sabina, Jennifer A. Kanakry, Christopher G. Kanakry

Blood Adv (2026) 10 (1): 1–13.

https://doi.org/10.1182/bloodadvances.2025016589

Published: 2026

Includes: Supplemental data

Journal Articles

Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years

Anna C. Ferreira, Debjani Dutta, Courtney M. Rowan, Jamie Renbarger, Kenneth R. Cooke, Paul A. Carpenter, Robert Krance, Christine Duncan, C. Russell Y. Cruz, David Jacobsohn, Catherine M. Bollard, Elizabeth Hill, Sophie Paczesny

Blood Adv (2026) 10 (1): 168–180.

https://doi.org/10.1182/bloodadvances.2025016624

Published: 2026

Includes: Supplemental data

Journal Articles

Targeting the lectin pathway in TA-TMA

Sonata Jodele

Blood Adv (2026) 10 (1): 181–182.

https://doi.org/10.1182/bloodadvances.2025018551

Published: 2026

Journal Articles

Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide

Dipenkumar Modi, Yosra M. Aljawai, Todd E. DeFor, Caitrin Bupp, Monzr M. Al Malki, Javier Bolaños-Meade, Mahasweta Gooptu, Antonio M. Jimenez Jimenez, Hongtao Liu, Felix A. Mensah, Marco Mielcarek, Brian C. Shaffer, Bronwen E. Shaw, Stephen R. Spellman, Heather E. Stefanski, Jeffery J. Auletta, Steven M. Devine, Farhad Khimani, Ramzi Abboud

Blood Adv (2026) 10 (1): 233–245.

https://doi.org/10.1182/bloodadvances.2025017194

Published: 2026

Includes: Supplemental data

Journal Articles

Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive care

Hiroyuki Matsui, Yasuyuki Arai, Junya Kanda, Tadakazu Kondo, Michelle L. Schoettler, Mohamad Mohty, Miguel-Angel Perales, Rafael F. Duarte, Alessandro Rambaldi, Akifumi Takaori-Kondo

Blood Adv (2026) 10 (1): 111–120.

https://doi.org/10.1182/bloodadvances.2025017540

Published: 2026

Journal Articles

A Proposal for Expedited Stem Cell Transplantation for TP53-Mutant Myelodysplastic Neoplasms and Acute Myeloid Leukemia

Shyam Ajay Patel, Steven M. Devine, Jan Cerny

Blood Adv bloodadvances.2025017795.

https://doi.org/10.1182/bloodadvances.2025017795

Published: 2025

Journal Articles

Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant Recipients

Blood Adv bloodadvances.2025017393.

https://doi.org/10.1182/bloodadvances.2025017393

Published: 2025

Includes: Supplemental data

Journal Articles

Abatacept today, TMA away: protecting the endothelium

Alexander Ngwube, Allistair Abraham

Blood Adv (2025) 9 (24): 6402–6403.

https://doi.org/10.1182/bloodadvances.2025018295

Published: 2025

Journal Articles

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

Pooja Khandelwal, Azada Ibrahimova, Adam Lane, Michael Grimley, Stella M. Davies, Sonata Jodele

Blood Adv (2025) 9 (24): 6370–6379.

https://doi.org/10.1182/bloodadvances.2025017197

Published: 2025

Includes: Supplemental data

Journal Articles

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation

Bhavna Bhasin-Chhabra, Tao Wang, John E. Levine, Shalini Shenoy, Miguel-Angel Perales, Asad Bashey, Hershel Raff, Wael Saber

Blood Adv (2025) 9 (24): 6394–6401.

https://doi.org/10.1182/bloodadvances.2025016655

Published: 2025

Includes: Supplemental data

Journal Articles

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

Blood Adv (2025) 9 (24): 6314–6325.

https://doi.org/10.1182/bloodadvances.2025017084

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction

Jeremy D. Rubinstein, Giang Pham, Anusha Sridharan, Ruby Khoury, YunZu M. Wang, Zahra Hudda, Jamie Wilhelm, Daniel A. Lichtenstein, Daria Heyenbruch, Jose A. Cancelas, Stella M. Davies, Carolyn Lutzko, Michael S. Grimley

Blood Adv (2025) 9 (24): 6305–6313.

https://doi.org/10.1182/bloodadvances.2025017097

Published: 2025

Includes: Supplemental data

Journal Articles

Validated Clinical Risk Score for Acute Graft-Versus-Host Disease in Adult Allogeneic Hematopoietic Cell Transplantation

Caden Ulschmid, Xiao Li, Tao Wang, Brent R. Logan, Joseph A Pidala, Margaret L. MacMillan, Carrie L. Kitko, Stephanie J. Lee, Stephen R. Spellman, Wael Saber

Blood Adv bloodadvances.2025016938.

https://doi.org/10.1182/bloodadvances.2025016938

Published: 2025

Includes: Supplemental data

Journal Articles

Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report

Jessie L Alexander, Blachy J. Dávila Saldaña, Ruta Brazauskas, Sravya Gethika Dammalapati, Linda M Griffith, Ami J. Shah, Kristin A Shimano, Hans D Ochs, Jack Bleesing, Christen L Ebens, Malika Kapadia, Andrea Bauchat, Neena Kapoor, Joseph H. Oved, Hesham Eissa, Hannah Lust, Michael D. Keller, Hilary Haines, Shanmuganathan Chandrakasan, Julie-An M. Talano, Ahmad Rayes, Lisa M. Madden, Evan B. Shereck, Holly K Miller, Lisa R Forbes Satter, Caridad A. Martinez, Jacob Rozmus, Jeffrey J Bednarski, Lolie C Yu, Deepakbabu Chellapandian, Victor M. Aquino, Alan P Knutsen, Hey Chong, Ashley Chopek, Alfred P Gillio, Avni Joshi, Hemalatha G. Rangarajan, Theodore B Moore, Jeffrey R. Andolina, Kenneth DeSantes, Mark T Vander Lugt, Susan E Prockop, David Shyr, Kathleen E. Sullivan, Suhag H Parikh, Katja G. Weinacht, Troy R. Torgerson, Rebecca A Marsh, Christopher C Dvorak, Alice Y Chan, Elie Haddad, Jennifer Heimall, Michael A. Pulsipher, Jennifer W Leiding, Donald B. Kohn, Jennifer M Puck, Luigi D Notarangelo, David J Rawlings, Morton J Cowan, Aleksandra Petrovic, Sung-Yun Pai, Lauri M. Burroughs

Blood Adv bloodadvances.2025017662.

https://doi.org/10.1182/bloodadvances.2025017662

Published: 2025

Includes: Supplemental data

Journal Articles

Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group

Blood Adv (2025) 9 (23): 6141–6157.

https://doi.org/10.1182/bloodadvances.2025016915

Published: 2025

Journal Articles

Fludarabine dosing in the youngest children: safety first

Rick Admiraal, Shelby Barnett, Caroline A Lindemans, Alwin D. R. Huitema, Gareth Veal

Blood Adv bloodadvances.2025018108.

https://doi.org/10.1182/bloodadvances.2025018108

Published: 2025

Journal Articles

Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations

Navid Djassemi, Benjamin Hanisch, Cecilia Motta, Naseem Maghzian, Anant Vatsayan, Jessica R. Durkee-Shock, Michael D. Keller

Blood Adv (2025) 9 (23): 5965–5975.

https://doi.org/10.1182/bloodadvances.2024013727

Published: 2025

Includes: Supplemental data

Journal Articles

Reproducibility and repeatability of the Myoton to quantify sclerotic chronic graft-versus-host disease

Nosha Farhadfar, Najla El Jurdi, Kelsey Baker, Shramana Ghosh, Mongoljin Bat-Erdene, MPH, Heidi Chen, Ruchi Sahu, Rachel Weiss, Jerry Mi, Gabriela Desatnik, Lacey R. Williams, Eric R Tkaczyk, Stephanie J. Lee

Blood Adv bloodadvances.2025016648.

https://doi.org/10.1182/bloodadvances.2025016648

Published: 2025

Includes: Supplemental data

Journal Articles

CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study

Blood Adv bloodadvances.2025018340.

https://doi.org/10.1182/bloodadvances.2025018340

Published: 2025

Includes: Supplemental data

Journal Articles

Successful engraftment in myeloablative transplant with cadaveric marrow after sudden unavailability of living donor.

Sumithira Vasu, Sarah A Wall, Karilyn Larkin, Sagar Munjal, Marcos J de Lima, Gabriela Sanchez-Petitto

Blood Adv bloodadvances.2025018888.

https://doi.org/10.1182/bloodadvances.2025018888

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant

Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years

Targeting the lectin pathway in TA-TMA

Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide

Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive care

A Proposal for Expedited Stem Cell Transplantation for TP53-Mutant Myelodysplastic Neoplasms and Acute Myeloid Leukemia

Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant Recipients

Abatacept today, TMA away: protecting the endothelium

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction

Validated Clinical Risk Score for Acute Graft-Versus-Host Disease in Adult Allogeneic Hematopoietic Cell Transplantation

Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report

Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group

Fludarabine dosing in the youngest children: safety first

Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations

Reproducibility and repeatability of the Myoton to quantify sclerotic chronic graft-versus-host disease

CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study

Successful engraftment in myeloablative transplant with cadaveric marrow after sudden unavailability of living donor.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only